We summarize the evidence on nerve-sparing retroperitoneal lymph node dissection for clinical stage IIA/B seminoma. When performed by expert surgeons, this procedure offers a chemotherapy-free survival rate of 80-85% with low morbidity.
European urology. 2025 Sep 15 [Epub ahead of print]
Axel Heidenreich, Anna Patrikidou, Torgrim Tandstad
Department of Urology, Uro-Oncology, Robot-assisted and Specialized Urologic Surgery, University Hospital Cologne, Cologne, Germany. Electronic address: ., Genitourinary Oncology Team, Department of Cancer Medicine, Gustave Roussy, Villejuif, France; Department of Early Drug Development, Gustave Roussy, Villejuif, France., Medical Oncology Department, St. Olav's Hospital, Trondheim, Norway.
PubMed http://www.ncbi.nlm.nih.gov/pubmed/40957845